Ray Dalio founded Bridgewater Associates in his Manhattan apartment in 1975 and grew it into a hedge fund colossus—with about $150 billion in assets—through astute analysis of macroeconomic trends. Al...
Tag: Sciences
Ray Dalio Sees More Pain Ahead in This Debt Cycle
Ray Dalio founded Bridgewater Associates in his Manhattan apartment in 1975 and grew it into a hedge fund colossus—with about $150 billion in assets—through astute analysis of macroeconomic trends. Al...
EXAS Stock Surges After Exact Sciences Raises Guidance On Massive Quarterly Beat
Exact Sciences (EXAS) massively beat third-quarter expectations Thursday and raised its full-year outlook — and EXAS stock jumped. X During the September quarter, Exact Sciences brought in $523.1 mill...
Should I buy Gilead Sciences shares in November 2022?
Gilead Sciences, Inc. (NASDAQ: GILD) shares have advanced from $61.45 to $80 since the beginning of October 2022, and the current price stands at $79.46. Gilead Sciences reported better-than-expected ...
Three US Economists Nab This Year’s Nobel Prize for Economic Sciences
The winners of the Nobel Economics prize are not just experts in their respective spheres but are renowned authorities whose positions and views about current global economic turmoil remain very respe...
Polestar Reported Strong EV Deliveries. Why the Stock Fell.
The latest delivery results from Polestar Automotive look solid, while the outlook for deliveries is even better. Investors seemed to be pleased before the September jobs number tanked the stock marke...
Credit Suisse, Tesla, Myovant Sciences and more
Take a look at some of the biggest movers in the premarket: Credit Suisse (CS) – Credit Suisse slid 6.1% in premarket trading after the bank sought to calm the fears of investors and clients about its...
Should you buy Cassava Sciences as the stock continue to soar
Retail interest in Cassava Sciences (NASDAQ:SAVA) remains far from over. The stock gained more than 6.7% on Wednesday, catapulting it to a 76% increase in value in a month. The Wednesday gains came as...
Whales go bullish on SAVA stock: where to buy the Cassava Sciences stock
The Cassava Sciences stock (NASDAQ: SAVA) has been very bullish over the past month. It has gained more than 58% in a span of 30 days and investors are still bullish on the stock. Yesterday, a whale w...
National Academy Of Sciences Report Slams Ligado
The National Academy of Sciences has released its long-awaited study on the effects of Ligado Networks operating a terrestrial network next to spectrum currently used for the Global Positioning System...
Bristol-Myers Squibb, Twitter, Gilead Sciences and more
Check out the companies making the biggest moves midday Monday: Gilead Sciences — Shares of Gilead rose 3.8% after the biopharmaceutical company revealed it settled a patent case over its HIV therapie...
Apple, Cassava Sciences, Canoo, more
Top trending after-hours tickers on Yahoo Finance: Apple (AAPL): Credit Suisse upgraded Apple to overweight from neutral, and raised the price target on the stock to $201 per share, implying a 16% ups...
Upstart stock drops after earnings, but CEO says he’s ‘confident’ in value of AI lending
Upstart Holdings Inc. delivered a lower-than-expected revenue forecast for the current quarter, but its chief executive expressed confidence in the performance and value of artificial-intelligence-dri...
Applied DNA Sciences pulls back after 6-fold surge in 2 days, after ‘upsized’ equity offering prices
Shares of Applied DNA Sciences Inc. APDN, +40.00% pulled back 5.1% in morning trading Thursday, after the biotechnology company announced the pricing of its “upsized” public equity offerin...
Gilead Sciences, CVS, Electronic Arts and more
A customer walks towards the entrance of a CVS Health Corp. store in downtown Los Angeles, California, U.S., on Friday, Oct. 27, 2017. Christopher Lee | Bloomberg | Getty Images Check out the companie...
Applied DNA Sciences blasts more than 350% higher after initiating validation of monkeypox virus test
Shares of Applied DNA Sciences Inc. APDN, +311.16% skyrocketed 353.7% higher in very volatile trading Tuesday, after the biotechnology company said it initiated validation of a monkeypox virus test. T...
Intel’s pain could be AMD’s gain
After a disastrous earnings report from Intel Corp. that acknowledged a big drop in data-center sales and internal mistakes, Advanced Micro Devices Inc. is expected up to show off exactly the opposite...
Google Parts With Engineer Who Claimed Its AI System Is Sentient
Google fired an engineer who contended that an artificial-intelligence chatbot the company developed had become sentient, telling him that he had violated the company’s data security policies after it...
This dividend fund is down 3% vs. S&P’s 20% drop. Here are its top stock picks
By now even the most ardent tech and growth-stock enthusiasts realize the bull market is over. John Kornitzer’s approach to selecting high-quality stocks for the Buffalo Flexible Income Fund is one th...
Polestar, a New EV Company, Arrives This Week. It’s Worth More Than Rivian.
Text size Polestar expects to ship 50,000 electric vehicles in 2022 and 124,000 in 2023. Courtesy Polestar Polestar, the electric vehicle maker being spun out of Volvo Car , should begin trading on Fr...
A New EV Company Arrives This Week. It’s Worth More Than Rivian.
Text size Polestar expects to ship 50,000 electric vehicles in 2022 and 124,000 in 2023. Courtesy Polestar Polestar, the electric vehicle maker being spun out of Volvo Car (ticker: VOLCARB.Sweden), sh...
Cloud software is suffering a cold November rain. Can Snowflake and Salesforce turn it around?
The week after Thanksgiving could determine if cloud software is still too fat or if there are some tasty leftovers for Wall Street. Autodesk Inc. ADSK, +1.82% signaled a slowdown in business spending...